menu ☰
menu ˟

How can the ‘omics’ revolution can change primary care

01 Feb 2017

Family medicine has reached a critical stage where we need to rethink how we practice. Patients with, or at risk of getting, multiple chronic diseases being treated with polypharmacy are becoming the norm in most developed, and now in developing, countries (1). Multiple guidelines, some with conflicting advice, are being produced by groups focusing on one disease with occasional exceptions (2). Technological innovations with telehealth, near-patient testing and remote monitoring add to the complexity. Challenges to continuity of care, with multiple specialists often involved with one patient, multiple charts and ineffective information technology all contribute to increasing the difficulty of delivering patient-centred evidence-informed care. The adverse drug reactions from the drugs we prescribe result in 197000 deaths in Europe every year (3) and are responsible for 9.5% of direct health care costs in the USA (4). It is against this background that the new technologies of genetics, genomics, proteomics, metabolomics and the microbiome are starting to become relevant to primary care (5).

Click here to view the full article which appeared in Family Practice